Immuneering Corporation (IMRX) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Immuneering Corporation

    NASDAQ: IMRX · Real-Time Price · USD
    8.08
    0.08 (1.00%)
    At close: Sep 26, 2025, 3:59 PM
    8.05
    -0.37%
    After-hours: Sep 26, 2025, 07:51 PM EDT

    Immuneering Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 36.15M 59.41M 72.64M 74.89M
    Short-Term Investments
    		 n/a 26.26M 32.89M 74.31M
    Long-Term Investments
    		 n/a n/a n/a 996.56K
    Other Long-Term Assets
    		 1.3M 1.03M 743.7K 102.13K
    Receivables
    		 n/a n/a 12.42K 246.04K
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 3.44M 3.42M 3.21M n/a
    Total Current Assets
    		 39.59M 89.08M 108.75M 152.33M
    Property-Plant & Equipment
    		 4.79M 5.4M 5.78M 6.13M
    Goodwill & Intangibles
    		 7.04M 7.07M 7.1M 7.14M
    Total Long-Term Assets
    		 13.13M 13.5M 13.62M 14.37M
    Total Assets
    		 52.71M 102.58M 122.37M 166.7M
    Account Payables
    		 1.96M 2.11M 3.15M 1.39M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 338.44K n/a n/a n/a
    Other Current Liabilities
    		 3.48M 3.89M 3.65M 2.92M
    Total Current Liabilities
    		 7.5M 7.85M 8.05M 5.63M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a
    Total Long-Term Liabilities
    		 3.82M 4.16M 4.46M 5.09M
    Total Liabilities
    		 11.33M 12.01M 12.52M 10.72M
    Total Debt
    		 4.16M 4.46M 4.84M 5.36M
    Book Value
    		 41.39M 90.58M 109.85M 155.98M
    Book Value Per Share
    		 1.38 3.19 4.16 5.93
    Common Stock
    		 31.05K 29.27K 26.42K 26.32K
    Retained Earnings
    		 -224.29M -163.26M -109.79M -59.27M
    Comprehensive Income
    		 n/a -778 -30.12K -49.01K
    Shareholders Equity
    		 41.39M 90.58M 109.85M 155.98M
    Total Investments
    		 n/a 26.26M 32.89M 75.31M

    Add to Watchlist